Caspase-11–Mediated Hepatocytic Pyroptosis Promotes the Progression of Nonalcoholic Steatohepatitis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Caspase-11–Mediated Hepatocytic Pyroptosis Promotes the Progression of Nonalcoholic Steatohepatitis
Authors
Keywords
-
Journal
Cellular and Molecular Gastroenterology and Hepatology
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-04-21
DOI
10.1016/j.jcmgh.2021.04.009
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NAFLD 2020: The State of the Disease
- (2020) Thomas G. Cotter et al. GASTROENTEROLOGY
- Caspase-11, a specific sensor for intracellular lipopolysaccharide recognition, mediates the non-canonical inflammatory pathway of pyroptosis
- (2019) Xiaoli Huang et al. Cell and Bioscience
- Cell death mechanisms in eukaryotes
- (2019) J. Grace Nirmala et al. CELL BIOLOGY AND TOXICOLOGY
- Increased liver localization of lipopolysaccharides in human and experimental non‐alcoholic fatty liver disease
- (2019) Guido Carpino et al. HEPATOLOGY
- Pyroptosis: An inflammatory link between NAFLD and NASH with potential therapeutic implications
- (2018) Juliane I. Beier et al. JOURNAL OF HEPATOLOGY
- Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice
- (2018) Bing Xu et al. JOURNAL OF HEPATOLOGY
- Caspase-11-mediated tubular epithelial pyroptosis underlies contrast-induced acute kidney injury
- (2018) Zhen Zhang et al. Cell Death & Disease
- Caspase-11 promotes renal fibrosis by stimulating IL-1β maturation via activating caspase-1
- (2018) Nai-jun Miao et al. ACTA PHARMACOLOGICA SINICA
- Caspase-11–mediated endothelial pyroptosis underlies endotoxemia-induced lung injury
- (2017) Kwong Tai Cheng et al. JOURNAL OF CLINICAL INVESTIGATION
- NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice
- (2017) Auvro R. Mridha et al. JOURNAL OF HEPATOLOGY
- Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
- (2017) Anna M. Diehl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intervention with a caspase-1 inhibitor reduces obesity-associated hyperinsulinemia, non-alcoholic steatohepatitis and hepatic fibrosis in LDLR−/−.Leiden mice
- (2016) M C Morrison et al. INTERNATIONAL JOURNAL OF OBESITY
- Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores
- (2016) Xing Liu et al. NATURE
- Targeting Cell Death and Sterile Inflammation Loop for the Treatment of Nonalcoholic Steatohepatitis
- (2016) Alexander Wree et al. SEMINARS IN LIVER DISEASE
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling
- (2015) Nobuhiko Kayagaki et al. NATURE
- Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
- (2015) Jianjin Shi et al. NATURE
- Update on Fatty Liver Disease and Steatohepatitis
- (2011) Fatima Zahra Aly et al. ADVANCES IN ANATOMIC PATHOLOGY
- Hepatic Free Cholesterol Accumulates in Obese, Diabetic Mice and Causes Nonalcoholic Steatohepatitis
- (2011) Derrick M. Van Rooyen et al. GASTROENTEROLOGY
- Non-canonical inflammasome activation targets caspase-11
- (2011) Nobuhiko Kayagaki et al. NATURE
- Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
- (2010) Christopher D. Williams et al. GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now